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Volume 51, Number 11S Abstracts 85STissue handling, efficiency and flow of operation were rated
significantly higher in the standardized group (mean range
88 to 96% vs mean range 67.6 to 77.6%; p 0.05). The
standardized group trended to better cognitive knowledge
(mean 68.8% vs 59.4%; p 0.182), creating a secure initial
knot, following the curve of the needle through tissue,
placing sutures accurately (70% vs 25%; p  0.08) and
securing the anastomosis at completion (100% vs 75%; p
0.183). 72% of participant evaluations suggested prefer-
ence for a standardized approach.
Conclusions: Standardization of teaching leads to
greater competency and excellent trainee acceptance when
performing a simulated vascular anastomosis. Transferabil-
ity of simulator-acquired skills to actual clinical settings will
be required before open simulation can be unequivocally
recommended as a major component of resident technical
skill training.
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Acute Mesenteric Ischemia: A Comparison of Endovas-
cular Revascularization to Traditional Therapy
Zachary M. Arthurs, Jessica M. Titus, Mohsen Ben-
nadazeh, Sunita Srivastava, Matthew J. Eagleton, Daniel G.
Clair. Vascular Surgery, Cleveland Clinic Foundation,
Cleveland, OH
Objectives: Few centers have adopted endovascular
therapy for the treatment of acute mesenteric ischemia. We
sought to evaluate the impact of endovascular therapy on
outcomes for the treatment of acute mesenteric ischemia
(AMI).
Methods: A single center, retrospective cohort review
was performed on all consecutive patients with thrombotic
or embolic AMI presenting between 1999-2008. Patients
with mesenteric venous thrombosis, non-occlusive mesen-
teric ischemia, and ischemia associated with aortic dissec-
tion were excluded. Demographic factors, preoperative
metabolic status, and etiology were compared. Primary
clinical outcomes included endovascular technical success,
operative complications, and in-hospital mortality.
Results: Seventy consecutive patients were identified
with AMI. Mean age was 64 ( 16) years; etiology of
mesenteric ischemia was 65% thrombotic and 35% embolic
occlusions. Endovascular revascularization was the pre-
ferred treatment (81%) vs operative therapy (19%). Success-
ful endovascular treatment was achieved in 87%. Endovas-
cular therapy required laparotomy in 69% vs traditional
therapy 100% (p  0.05) with a median 52cm necrotic
bowel resected (Interquartile range (IQR): 11-140cm) vs160cm (IQR: 90-250cm, p  0.05), respectively. Acute
renal failure and pulmonary failure occurred less frequently
with endovascular therapy (27% vs 50%, p  0.05 and 27%
vs 70%, p  0.05). Endovascular treatment resulted in a
mortality rate of 39% compared to 53% (p  0.05) with
traditional therapy. Successful endovascular treatment
equated to a mortality of 36%, whereas the mortality for
endovascular failures was 50%. Endovascular therapy was
associated with improved mortality in thrombotic AMI
(Odds Ratio  0.10, 95% Confidence Interval; 0.10-0.76,
p  0.05).
Conclusions: Endovascular therapy has altered the
management of AMI, and there are measurable advantages
to this approach. Utilizing endovascular therapy as the
primary modality for AMI reduces complications and im-
proves outcomes.
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Routine Venography Following Transaxillary First Rib
(FRRS) Resection for Subclavian Vein Thrombosis
Ensures Excellent Outcomes and Vein Patency
Julie A. Freischlag, Kevin Chang, Jasmine Demos, James
Black. Johns Hopkins, Baltimore, MD
Objectives: The purpose of this study is to assess the
role of routine postoperative venography in patients who
have undergone FRRS for subclavian vein thrombosis by
evaluating long-term vein patency using imaging by duplex
scan.
Methods: Patients treated with FRRS undergo a
venogram 2 weeks postoperatively. The subclavian vein is
dilated if there is a 50% stenosis and those patients are
then anticoagulated. If no stenosis is seen, anticoagulation
is stopped. If the vein is occluded, anticoagulation is con-
tinued for 6 months or until the vein recanalizes.
Results: Eighty four patients (42 males and 42 fe-
males) underwent FRRS between 12/03 and 11/09. For-
ty-eight patients with stenotic veins underwent dilation; 4
had acute thrombus and were lysed as well as dilated and 3
thrombosed following the venogram and were anticoagu-
lated. All patients remained on anticoagulation on average
for 2 (1-5) months. Twenty-ne patients had patent veins
and remained open in the follow-up period. Chronically
occluded veins were seen in 16 patients. They remained on
anticoagulation for an average of 3 (1-8) months and 14
patients recanalized following FRRS in the first 6 months.
Percent patency by Kaplan Meier is seen in the graph. In
follow-up, symptomatic restenosis was seen in 3 patients
and those veins were redilated. Two patients had late
occlusions at 2 years. These 5 patients were all in the dilated
group.
